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INTRODUCTION 
In the previous educational articles, we explained 
how to calculate the sample size for a rate or a 
single proportion, for an independent cohort study, 
for an independent case-control study, and for a 
diagnostic test accuracy study (1-4). In this article, 
we explain how to calculate the sample size for a 
superiority clinical trial. 
WHEN TO USE THE SAMPLE SIZE CALCULATION 
PROCEDURE OF SUPERIORITY CLINICAL TRIAL 
The methods explained hereafter should be used in 
the case that the superiority clinical trial is 
comparing two interventions with the endpoint 
being continuous data expressed as the mean 
difference. 
REQUIREMENTS  
1) Expected effect size (ES) 
2) Type of clinical trial: Cross over or parallel 
3) Allocation ratio between the experimental and 
control groups 
4) Statistical power 
5) Alpha 
The expected ES differs according to the type of 
outcome measure. In case of continuous measures, 
the required ES will be the expected mean 
difference between the two arms and the standard 
deviation (SD) of the mean difference. In the case of 
binary outcomes (events as death or remission), 
the required ES will be the expected rate of event 
in each group. 
CALCULATION STEPS 
1) Open SampSize application on your mobile 
2) Select superiority from the type of trial 
(superiority, non-inferiority, or equivalence)  
3) Select parallel for the design of the study 
(parallel or cross over) 
4) Select normal for the type of outcome data 
(normal or binary)  
5) Put the data into space and click “calculate.” 
CASE STUDY OF SUBTHALAMIC VERSUS PALLIDAL DEEP 
BRAIN STIMULATION FOR PATIENTS WITH 
PARKINSON’S DISEASE 
Assume that we are conducting a randomized 
controlled trial to compare the subthalamic (STN) 
and pallidal (GPi) deep brain stimulation (DBS) for 
patients with Parkinson’s disease. The primary 
outcome measure of this study is the improvement 
in motor function measured by the unified 
Parkinson’s disease rating scale (UPDRS-III). The 
most recent report comparing the two targets was 
published by Odekerken et al. (5) where the STN 
DBS and GPi DBS resulted in 20.3 and 11.4 point-
improvements on the UPDRS-III, respectively. The 
SD of the motor functions (UPDRS-III) of two 
groups at baseline were 13.5 and 15.5, respectively. 
CASE SOLUTION 
First, we determine the requirements 
 Expected mean difference between the two 
arms: 20.3 - 11.4 = 8.9 
 SD = √𝑆𝐷. 𝑒𝑥𝑝𝑒𝑟𝑖𝑚𝑒𝑛𝑡𝑎𝑙2 + 𝑆𝐷. 𝑐𝑜𝑛𝑡𝑟𝑜𝑙2 = 20 
 Type of clinical trial: parallel 
 Allocation ratio between the experimental and 
control groups: 1 
 Statistical power: 90% 
 Alpha: 5% 
Second, we run the calculations as shown in figure 
1. The results show that a minimum sample size of 
216 patients (n=108 per group) will be required for 
this randomized controlled trial. 
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Figure 1: Calculating the sample size for a superiority clinical trial using an application 
